Report cover image

Asthma Treatment Global Market Report 2025

Publisher The Business Research Company
Published Sep 10, 2025
Length 250 Pages
SKU # BRC20386749

Description

Asthma Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on asthma treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

    • Description:

    Where is the largest and fastest growing market for asthma treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The asthma treatment market global report from the Business Research Company answers all these questions and many more.

    The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

    • Scope

    Markets Covered:1) By Treatment: Long-Term Control Medications; Quick-Relief Medications

    2) By Device Type: Inhalers; Dry Powder; Metered Dose; Soft Mist Nebulizers

    3) By Drug Class: Short-Acting Beta-Agonists (SABA); Long-Acting Beta-Agonists (LABA); Inhaled Corticosteroids (ICS); Leukotriene Modifiers; Immunomodulators; Combination Drugs; Other Drug Class

    4) By Route Of Administration: Oral; Inhaled; Intravenous; Subcutaneous

    5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels

    Subsegments:

    1) By Long-Term Control Medications: Inhaled Corticosteroids (ICS); Long-Acting Beta-Agonists (LABA); Leukotriene Receptor Antagonists (LTRA); Long-Acting Muscarinic Antagonists (LAMA); Methylxanthines; Biologics

    2) By Quick-Relief Medications: Short-Acting Beta-Agonists (SABA); Systemic Corticosteroids; Anticholinergics

    Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Novartis AG; Sanofi S.A.; AstraZeneca PLC; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Amgen Inc.; Boehringer Ingelheim International GmbH; Teva Pharmaceutical Industries Limited; Regeneron Pharmaceuticals Inc.; Sun Pharmaceutical Industries Limited; Genentech Inc.; Sumitomo Pharma Co Ltd.; Chiesi Farmaceutici S.p.A.; Cipla Limited.

    Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.

    Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

    Time Series: Five years historic and ten years forecast.

    Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

    Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

    Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

    Delivery Format: PDF, Word and Excel Data Dashboard.

    Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

    Table of Contents

    250 Pages
    1. Executive Summary
    2. Asthma Treatment Market Characteristics
    3. Asthma Treatment Market Trends And Strategies
    4. Asthma Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
    5. Global Asthma Treatment Growth Analysis And Strategic Analysis Framework
    5.1. Global Asthma Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
    5.2. Analysis Of End Use Industries
    5.3. Global Asthma Treatment Market Growth Rate Analysis
    5.4. Global Asthma Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
    5.5. Global Asthma Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
    5.6. Global Asthma Treatment Total Addressable Market (TAM)
    6. Asthma Treatment Market Segmentation
    6.1. Global Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    Long-Term Control Medications
    Quick-Relief Medications
    6.2. Global Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    Inhalers
    Dry Powder
    Metered Dose
    Soft Mist Nebulizers
    6.3. Global Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    Short-Acting Beta-Agonists (SABA)
    Long-Acting Beta-Agonists (LABA)
    Inhaled Corticosteroids (ICS)
    Leukotriene Modifiers
    Immunomodulators
    Combination Drugs
    Other Drug Class
    6.4. Global Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    Oral
    Inhaled
    Intravenous
    Subcutaneous
    6.5. Global Asthma Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies
    Other Distribution Channels
    6.6. Global Asthma Treatment Market, Sub-Segmentation Of Long-Term Control Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    Inhaled Corticosteroids (ICS)
    Long-Acting Beta-Agonists (LABA)
    Leukotriene Receptor Antagonists (LTRA)
    Long-Acting Muscarinic Antagonists (LAMA)
    Methylxanthines
    Biologics
    6.7. Global Asthma Treatment Market, Sub-Segmentation Of Quick-Relief Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    Short-Acting Beta-Agonists (SABA)
    Systemic Corticosteroids
    Anticholinergics
    7. Asthma Treatment Market Regional And Country Analysis
    7.1. Global Asthma Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    7.2. Global Asthma Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    8. Asia-Pacific Asthma Treatment Market
    8.1. Asia-Pacific Asthma Treatment Market Overview
    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
    8.2. Asia-Pacific Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    8.3. Asia-Pacific Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    8.4. Asia-Pacific Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    9. China Asthma Treatment Market
    9.1. China Asthma Treatment Market Overview
    9.2. China Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
    9.3. China Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
    9.4. China Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
    10. India Asthma Treatment Market
    10.1. India Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    10.2. India Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    10.3. India Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    11. Japan Asthma Treatment Market
    11.1. Japan Asthma Treatment Market Overview
    11.2. Japan Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    11.3. Japan Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    11.4. Japan Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    12. Australia Asthma Treatment Market
    12.1. Australia Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    12.2. Australia Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    12.3. Australia Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    13. Indonesia Asthma Treatment Market
    13.1. Indonesia Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    13.2. Indonesia Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    13.3. Indonesia Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    14. South Korea Asthma Treatment Market
    14.1. South Korea Asthma Treatment Market Overview
    14.2. South Korea Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    14.3. South Korea Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    14.4. South Korea Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    15. Western Europe Asthma Treatment Market
    15.1. Western Europe Asthma Treatment Market Overview
    15.2. Western Europe Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    15.3. Western Europe Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    15.4. Western Europe Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    16. UK Asthma Treatment Market
    16.1. UK Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    16.2. UK Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    16.3. UK Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    17. Germany Asthma Treatment Market
    17.1. Germany Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    17.2. Germany Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    17.3. Germany Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    18. France Asthma Treatment Market
    18.1. France Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    18.2. France Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    18.3. France Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    19. Italy Asthma Treatment Market
    19.1. Italy Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    19.2. Italy Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    19.3. Italy Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    20. Spain Asthma Treatment Market
    20.1. Spain Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    20.2. Spain Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    20.3. Spain Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    21. Eastern Europe Asthma Treatment Market
    21.1. Eastern Europe Asthma Treatment Market Overview
    21.2. Eastern Europe Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    21.3. Eastern Europe Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    21.4. Eastern Europe Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    22. Russia Asthma Treatment Market
    22.1. Russia Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    22.2. Russia Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    22.3. Russia Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    23. North America Asthma Treatment Market
    23.1. North America Asthma Treatment Market Overview
    23.2. North America Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    23.3. North America Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    23.4. North America Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    24. USA Asthma Treatment Market
    24.1. USA Asthma Treatment Market Overview
    24.2. USA Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    24.3. USA Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    24.4. USA Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    25. Canada Asthma Treatment Market
    25.1. Canada Asthma Treatment Market Overview
    25.2. Canada Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    25.3. Canada Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    25.4. Canada Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    26. South America Asthma Treatment Market
    26.1. South America Asthma Treatment Market Overview
    26.2. South America Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    26.3. South America Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    26.4. South America Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    27. Brazil Asthma Treatment Market
    27.1. Brazil Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    27.2. Brazil Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    27.3. Brazil Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    28. Middle East Asthma Treatment Market
    28.1. Middle East Asthma Treatment Market Overview
    28.2. Middle East Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    28.3. Middle East Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    28.4. Middle East Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    29. Africa Asthma Treatment Market
    29.1. Africa Asthma Treatment Market Overview
    29.2. Africa Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    29.3. Africa Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    29.4. Africa Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    30. Asthma Treatment Market Competitive Landscape And Company Profiles
    30.1. Asthma Treatment Market Competitive Landscape
    30.2. Asthma Treatment Market Company Profiles
    30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    31. Asthma Treatment Market Other Major And Innovative Companies
    31.1. Bayer AG
    31.2. Novartis AG
    31.3. Sanofi S.A.
    31.4. AstraZeneca PLC
    31.5. GlaxoSmithKline plc
    31.6. Takeda Pharmaceutical Company Limited
    31.7. Amgen Inc.
    31.8. Boehringer Ingelheim International GmbH 
    31.9. Teva Pharmaceutical Industries Limited
    31.10. Regeneron Pharmaceuticals Inc.
    31.11. Sun Pharmaceutical Industries Limited
    31.12. Genentech Inc.
    31.13. Sumitomo Pharma Co Ltd.
    31.14. Chiesi Farmaceutici S.p.A.
    31.15. Cipla Limited
    32. Global Asthma Treatment Market Competitive Benchmarking And Dashboard
    33. Key Mergers And Acquisitions In The Asthma Treatment Market
    34. Recent Developments In The Asthma Treatment Market
    35. Asthma Treatment Market High Potential Countries, Segments and Strategies
    35.1 Asthma Treatment Market In 2029 - Countries Offering Most New Opportunities
    35.2 Asthma Treatment Market In 2029 - Segments Offering Most New Opportunities
    35.3 Asthma Treatment Market In 2029 - Growth Strategies
    35.3.1 Market Trend Based Strategies
    35.3.2 Competitor Strategies
    36. Appendix
    36.1. Abbreviations
    36.2. Currencies
    36.3. Historic And Forecast Inflation Rates
    36.4. Research Inquiries
    36.5. The Business Research Company
    36.6. Copyright And Disclaimer

    Pricing

    Currency Rates
    How Do Licenses Work?

    How Do Licenses Work?

    The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

    • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

    • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

    • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

    • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

    • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

    License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
    Chat Now
    Contact Us